Class II · ModerateActive recall
fentaNYL Citrate Injectable Solution
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot 011226204250063, Exp Date 05/14/2026
Where it was soldU.S. Nationwide.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
cGMP deviations.
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | Wells Pharma of Houston LLC |
| NDC | 73702-204-25 |
Show the full FDA record
| Full product label | fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25. |
| Recalling firm | Wells Pharma of Houston LLC |
| Distribution | U.S. Nationwide. |
| Quantity | 50 syringes |
| Recall initiated | 2026-04-01 |
| Report date | 2026-05-06 |
| Recall completed | — |
| Recall number | D-0505-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Houston TX United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.